New Benchmark and Model Advance Gene Regulatory Network Inference

Jiaze Song, Runhao Zhao, Minghao Xu, Bin Cui, Wentao Zhang· July 16, 2026 View original

Key takeaways

  • Existing GRN inference benchmarks often misalign with real-world biological discovery needs.
  • BEELINE-KGC is a new benchmark for inductive, ranking-centric GRN inference.
  • CoDiffGRN is a novel co-evolutionary discrete diffusion framework for GRN inference.
  • CoDiffGRN achieves state-of-the-art performance in discovering novel regulatory interactions.

Who benefits

BiotechnologyPharmaceuticalsHealthcareLife SciencesAcademia

Summary

This paper introduces BEELINE-KGC, a new benchmark for gene regulatory network (GRN) inference that focuses on inductive, ranking-centric graph completion, better reflecting real-world biological discovery needs. It also proposes CoDiffGRN, a co-evolutionary discrete diffusion framework that achieves state-of-the-art performance in novel regulatory discovery and inductive generalization.

Inferring gene regulatory networks (GRNs) from single-cell transcriptomic data is crucial for biological research, but existing methods and benchmarks often fail to align with practical needs. Current evaluations rely on transductive splits and global classification metrics, which don't adequately assess a model's ability to discover novel interactions involving previously unseen genes. To bridge this gap, researchers have reformulated GRN inference as an inductive, ranking-centric graph completion problem. They introduce BEELINE-KGC, a new benchmark that incorporates an inductive gene-holdout split and uses knowledge graph completion metrics to better evaluate top-ranked predictions, reflecting how biologists seek high-confidence interactions for validation. Building on this, the paper proposes CoDiffGRN, the first co-evolutionary discrete diffusion framework. CoDiffGRN jointly models biologically coherent discretized gene expression states and regulatory interactions, leading to robust inductive generalization and improved discovery of novel regulatory elements. It also includes TF-ALL Subgraph Sampling (TASS) for scalable training, demonstrating state-of-the-art performance on the new benchmark.

Why it matters

Professionals in biotechnology, pharmaceuticals, and bioinformatics can leverage this advanced GRN inference to accelerate drug discovery, understand disease mechanisms, and identify new therapeutic targets with higher confidence.

How to implement this in your domain

  1. 1Adopt the BEELINE-KGC benchmark as a standard for evaluating generative molecular models in drug discovery pipelines.
  2. 2Explore integrating co-evolutionary discrete diffusion frameworks like CoDiffGRN for improved GRN inference.
  3. 3Focus on inductive generalization capabilities when developing or selecting GRN inference tools, especially for novel gene discovery.
  4. 4Utilize TF-ALL Subgraph Sampling (TASS) to scale GRN inference training on large single-cell transcriptomic datasets.
  5. 5Collaborate with bioinformaticians to apply CoDiffGRN to specific biological discovery projects, such as drug target identification.

Original post by Jiaze Song, Runhao Zhao, Minghao Xu, Bin Cui, Wentao Zhang

"arXiv:2607.13120v1 Announce Type: new Abstract: Inferring gene regulatory networks (GRNs) from single-cell transcriptomic data is crucial for biological discovery, yet existing approaches suffer from a fundamental misalignment with real-world needs. Researchers typically seek a s…"

View on X

Originally posted by Jiaze Song, Runhao Zhao, Minghao Xu, Bin Cui, Wentao Zhang on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses